1060 Capital, LLC
•CIK: 1602119•Filing: Q4 2025
**1060 Capital, LLC** manages $36M across a concentrated portfolio of six positions. The fund exhibits significant conviction in biotechnology and healthcare, with its largest allocation to CTRI at $20.8M. Further notable holdings include substantial positions in THR and CHR, each representing $4.6M. This structure suggests a focused, high-conviction approach targeting specific growth catalysts within the life sciences sector.
Total AUM
$32.9M
+ $3.5M in options
QoQ Performance
+30.1%
Positions
5
+ 1 option
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
CTRI
THR
CHR
ACEL
DHR
CTRI57.2%
THR12.7%
CHR12.5%
ACEL9.7%
DHR5.0%
FLL2.9%
📈 Biggest Buys
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other95.0%
Healthcare5.0%
🚪 Exited Positionssold since Q3 2025
+3 more exited positions
Changes from Q3 2025
NEW5 new positions
↑1 increased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023